{"page_content": "ESG R eport 2021AGIOS PHARMACEUTICALS  \nCORPORATE SUSTAINABILITY TEAR SHEET\nAt Agios, we are committed to building a sustainable business that provides \nlong-term value for all our stakeholders. We support environmental, social and \ngovernance (ESG) initiatives that are aligned with our culture and values and that \nmay positively impact the patients we serve, our employees, our communities \nand our world.\nThis document contains disclosure of sustainability metrics relevant to Agios\u2019 \nbusiness and strategy. These metrics are aligned with the Sustainability \nAccounting Standards Board (SASB) standards for the Biotechnology and \nPharmaceuticals Industry and the United Nations Sustainable Development \nGoals (UN SDGs). Unless otherwise noted, it covers ESG disclosures for Agios \nPharmaceuticals for the period Jan. 1, 2020 through Dec. 31, 2020.\n2", "metadata": {"source": "NASDAQ_AGIO_2020.pdf", "page": 1, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}